Marauder93 said...
malaika said...
I'm fairly sure that in Europe the drug has not been approved because it's too unsafe.
This is true for RA I think? But ya, its similar to Remicade because it acts systemicallyhttp://www.medicalnewstoday.com/articles/259752.php
This is about
its use in rheumatoid arthritis, but I think it was banned for most if not all diseases. It says:
'The Committee was also concerned about
the raised risk of other serious side effects, such as liver damage, problems with increased lipid blood levels, certain cancers, and gastro-intestinal perforations. The Committee added "It was not clear that these risks could be managed successfully in medical practice. Therefore, at that point in time, the CHMP was of the opinion that the benefits of Xeljanz did not outweigh its risks and recommended that it be refused marketing authorisation.'